Skip to content

Comparison of incidences of AMD after implantation of IOLs with and without blue light blocking.

Comparison of incidences of age-related macular degeneration after implantation of intraocular lenses with and without blue light blocking.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs072190056
Enrollment
278
Registered
2020-03-27
Start date
2020-06-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Cataract

Interventions

Group A: Implantation of a intraocular lens with blue light blocking Group B: Implantation of a intraocular lens without blue light blocking

Sponsors

Mori Yosai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients without AMD nor its precursor lesions who are able to receive an ocular fundus examination before cataract surgery 2) Patients aged 50 years or older and below 75 years who are planned for cataract extraction by phacoemulsification 3) Patients with IOL fixed in the capsule 4) Patients with a calculated lens dioptric power within the target range of the investigational IOL 5) Patients with an expected postoperative CDVA of 0.5 or better 6) Patients who are able to cooperate with the postoperative follow-up 7) Enrollment of patients with the following a) - i) conditions shall be carefully considered by investigators. a) Cornea endothelial disorder with the cell count less than 500 cells/mm2 b) Glaucoma c) Histories of uveitis d) Diabetic retinopathy e) Pseudoexfoliation syndrome f) High myopia g) Congenital ocular abnormalities h) Severe ciliary zonular dehiscenece i) With some problems in the capsular bag during the operation

Exclusion criteria

Exclusion criteria: 1) AMD or its precursor lesions 2) Histories of retinal detachment 3) Histories of vitreous surgery 4) Patient with active uveitis 5) Patients with iris neovascularization 6) Atopic cataract 7) Serious intraoperative complications 8) Meeting the inclusion criterion 7) and judged to be ineligible 9) Judged to be ineligible by investigators for the reason of other systemic or ophthalmic disease 10) In single eye status or already implanted with other IOL in one eye

Design outcomes

Primary

MeasureTime frame
The incidence of wet-AMD for 3 years after surgery

Secondary

MeasureTime frame
1) Compare the incidence of wet AMD precursor lesions or fundus abnormalities determined via fundus photography, FAF, OCT, OCTA or fluorescein angiography. 2) Since the amount of visible light transmitted through the eye may differ depending on the pupil diameter, the pupil diameter is compared between the two groups. 3) Compare the transition of distant corrected visual acuity after surgery.

Contacts

Public ContactAkiko Yagi

Oculus Co.Ltd.

officeplusi2012@mbr.nifty.com+81-986-25-6889

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026